1. Home
  2. SNDA vs URGN Comparison

SNDA vs URGN Comparison

Compare SNDA & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonida Senior Living Inc.

SNDA

Sonida Senior Living Inc.

HOLD

Current Price

$36.92

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$28.85

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNDA
URGN
Founded
1990
2004
Country
United States
United States
Employees
N/A
291
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
SNDA
URGN
Price
$36.92
$28.85
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$35.75
$29.29
AVG Volume (30 Days)
617.1K
829.4K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$381,141,000.00
$1,128,000.00
Revenue This Year
$68.73
$129.09
Revenue Next Year
$11.11
$70.96
P/E Ratio
N/A
N/A
Revenue Growth
25.24
N/A
52 Week Low
$23.66
$3.61
52 Week High
$39.66
$32.37

Technical Indicators

Market Signals
Indicator
SNDA
URGN
Relative Strength Index (RSI) 51.75 59.44
Support Level $30.78 $17.86
Resistance Level $38.74 $30.00
Average True Range (ATR) 1.93 2.04
MACD -0.19 -0.08
Stochastic Oscillator 58.23 62.90

Price Performance

Historical Comparison
SNDA
URGN

About SNDA Sonida Senior Living Inc.

Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic services offered by the company at its senior housing communities comprise meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

Share on Social Networks: